N
Noxilizer
Noxilizer's NO2-based sterilization process for medical device manufacturers.
About Noxilizer
Noxilizer specializes in providing advanced sterilization solutions using proprietary Nitrogen Dioxide (NO2) technology. The company caters to pharmaceutical, biotech, and medical device manufacturers, offering both sterilization equipment and contract sterilization services. Operating in the healthcare and life sciences market, Noxilizer's business model revolves around selling its unique NO2 sterilization equipment and providing ongoing sterilization services. This dual approach allows the company to generate revenue from both product sales and service contracts. Noxilizer's technology is particularly effective for sterilizing polymer-based prefilled syringes, ensuring drug integrity and minimizing the risk of adverse effects. The company also boasts a team of expert microbiologists and material compatibility specialists who collaborate with clients to address complex sterilization challenges.
Source: Dealroom company dataAt a glance
- Founded
- 2004
- Headquarters
- Severn, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Industrial Growth Platform
NewVale Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Noxilizer on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Noxilizer on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.